TrialBlood2023

Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial.

John F Seymour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.